Researchers from the National Defense Medical Center in Taiwan have identified an increased risk of psoriasis in patients with cancer undergoing immune checkpoint inhibitor (ICI) treatments, with implications for other immune-related adverse events.
from Medical Xpress - latest medical and health news stories https://ift.tt/nZkzHCK
